1. Home
  2. CET vs CERT Comparison

CET vs CERT Comparison

Compare CET & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CET

Central Securities Corporation

HOLD

Current Price

$50.85

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$8.81

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CET
CERT
Founded
1929
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CET
CERT
Price
$50.85
$8.81
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$13.25
AVG Volume (30 Days)
38.3K
2.1M
Earning Date
01-01-0001
11-06-2025
Dividend Yield
4.54%
N/A
EPS Growth
N/A
N/A
EPS
7.40
0.07
Revenue
$27,062,484.00
$415,551,000.00
Revenue This Year
N/A
$10.80
Revenue Next Year
N/A
$6.47
P/E Ratio
$6.85
$130.24
Revenue Growth
15.78
11.47
52 Week Low
$40.24
$8.03
52 Week High
$52.44
$15.69

Technical Indicators

Market Signals
Indicator
CET
CERT
Relative Strength Index (RSI) 53.32 42.67
Support Level $50.60 $8.71
Resistance Level $51.31 $8.94
Average True Range (ATR) 0.66 0.28
MACD 0.04 0.04
Stochastic Oscillator 58.90 44.25

Price Performance

Historical Comparison
CET
CERT

About CET Central Securities Corporation

Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: